Meet people from Immatics at Phacilitate Cell & Gene Therapy World 2017!
Immatics will be participating in panel “Ensuring Next-Generation Cellular Immunotherapies Build on Recent Clinical Successes in ALL” to discuss how to enable the move beyond CD19 and NY-ESO for adoptive T-cell immunotherapy:

Wednesday, Jan 18
2.30pm – 4.15pm
Harpreet Singh (CSO), Immatics

For further information please contact us!
For more information on Phacilitate Cell & Gene Therapy World 2017: click